Crystal Structure of CHK1 with an Indol Inhibitor
The structure was published by Lin, N.-H., Xia, P., Kovar, P., et al., Zhang, H., Rosenberg, S.H., and Sham, H.L., in 2006 in a paper entitled "Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitors" (abstract).
This crystal structure was determined using X-ray diffraction at a resolution of 2.9 Å and deposited in 2005.
The experimental data on which the structure is based was not deposited.
The PDB entry contains the structure of Serine/threonine-protein kinase Chk1. This molecule has the UniProt identifier O14757 (CHK1_HUMAN). The sample contained 269 residues which is < 90% of the natural sequence. Out of 269 residues 268 were observed and are deposited in the PDB.
It also contains one or more heterogenic compounds (e.g., ligands, co-factors, ions, modified amino acids, etc.); see here for a complete list.
The molecule is most likely monomeric.
The following tables show cross-reference information to other databases (to obtain a list of all PDB entries sharing the same property or classification, click on the magnifying glass icon):
This entry contains 1 unique UniProt protein: